OTC · Medical - Devices

Cochlear Limited (CHEOY) Stock

$39.03 -6.02% OTC: CHEOY Healthcare

Cochlear Limited is a global healthcare company specializing in advanced auditory solutions. It develops and manufactures surgically implanted hearing devices for individuals of all ages, from children to adults, across the world.

Valuation

MetricValue
Price$39.03
Market Cap$5.11B
P/E Ratio21.25
P/B Ratio3.79
P/S Ratio3.11
EPS (TTM)$1.84
52-Week High$105.60
52-Week Low$31.82
Dividend Yield3.89%

Financials & Margins

MetricValue
ROE17.76%
ROA12.36%
ROCE21.12%
Gross Margin73.03%
Operating Margin19.98%
Net Margin14.62%
Debt/Equity0.22
Current Ratio2.46

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.5B$1.6B$2.0B$2.2B$2.3B
Operating Profit$328.0M$362.0M$412.0M$475.0M$406.0M
Net Profit$327.0M$289.0M$301.0M$357.0M$389.0M
EPS$2.47$2.20$2.28$2.72$2.97
Op Margin22.0%22.0%21.1%21.3%17.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.4B$2.5B$2.6B$2.7B$2.8B
Total Liabilities$737.0M$779.0M$820.0M$905.0M$875.0M
Cash$610.0M$629.0M$556.0M$514.0M$276.0M
Borrowings$264.0M$254.0M$202.0M$244.0M$236.0M

Latest News

Cochlear introduces the new Osia® 3 Sound Processor PR Newswire · Jul 13, 2026 Don't Miss the Moments That Matter This Summer: Hearing Experts and Cochlear Encourage People to Check Their Hearing Health PR Newswire · Jun 26, 2026 [Latest] Global Ear Health Market Size/Share Worth USD 16.87 Billion by 2035 at a 5.7% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) GlobeNewswire · Jun 17, 2026 Better Hearing and Whole-Body Health: What to Know About MRI Access with Cochlear Implants PR Newswire · May 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$265.0M$377.0M$362.0M$389.0M$238.0M
Investing Cash Flow$213.0M$-310.0M$-297.0M$-195.0M$-218.0M
Financing Cash Flow$-20.0M$-26.0M$-72.0M$-78.0M$-89.0M
Net Cash Flow$45.0M$20.0M$-74.0M$-42.0M$-238.0M
Free Cash Flow$199.0M$299.0M$267.0M$299.0M$135.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-3.24
EV / EBITDA13.36
FCF Yield2.74%
Quick Ratio1.44
Interest Coverage40.69
Return 1Y-60.56%
Return 3Y-48.54%
Return 5Y-55.84%

Ownership

Insiders Held0.00%
Institutions Held0.01%
Institutions Float Held0.01%
Institutional HolderSharesReport Date
Salomon & Ludwin, LLC472026-03-31
Rhumbline Advisers4,1442026-03-31
Gamma Investing LLC1,9322026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALBBYAlibaba Health Information Technology Limited $8.60 -7.63% 24.56 $6.93B 0.00%
BDUUYBangkok Dusit Medical Services Public Company Limited $23.41 +0.00% 20.00 $9.30B 6.83%
CHJTFCSPC Pharmaceutical Group Limited $0.98 +0.00% 21.72 $11.18B 4.08%
ERFSFEurofins Scientific SE $81.74 +5.24% 27.93 $14.14B 1.03%
FSPKFFisher & Paykel Healthcare Corporation Limited $22.96 +0.26% 50.28 $13.48B 2.57%

About Cochlear Limited

Cochlear Limited is a global healthcare company specializing in advanced auditory solutions. It develops and manufactures surgically implanted hearing devices for individuals of all ages, from children to adults, across the world. The company's diverse product range features cochlear implant systems, enhanced sound processor upgrades, bone conduction technology, and a variety of complementary accessories and related items. Founded in 1981, Cochlear Limited is headquartered in Sydney, Australia.

Cochlear Limited is headquartered in AU.

Cochlear Limited (CHEOY) stock trades at $39.03 with a market capitalization of $5.11B. The stock is valued at a price-to-earnings (P/E) ratio of 21.25, price-to-book of 3.79, price-to-sales of 3.11. Over the past 52 weeks the stock has ranged between $31.82 and $105.60, and currently trades 63.0% below its 52-week high. It pays a dividend yielding 3.89%.

On profitability, Cochlear Limited generates a return on equity (ROE) of 17.76%, above the typical market average, return on capital employed of 21.12%, an operating margin of 19.98%, a net profit margin of 14.62%.

Official website: www.cochlear.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides